We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+11.22%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.92B
AUM Growth
-$861M
Cap. Flow
-$1.08B
Cap. Flow %
-56.34%
Top 10 Hldgs %
24.9%
Holding
1,961
New
419
Increased
272
Reduced
381
Closed
669

Top Buys

Rank Stock Value
1
BEKE icon
KE Holdings
BEKE
+$13.6M
2
TSM icon
TSMC
TSM
+$11.4M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$11.3M
4
AMAT icon
Applied Materials
AMAT
+$9.44M
5
AVEO
AVEO Pharmaceuticals, Inc.
AVEO
+$6.99M

Top Sells

Rank Stock Value
1
KAHC
KKR Acquisition Holdings I Corp.
KAHC
+$30.7M
2
TWTR
Twitter, Inc.
TWTR
+$30.3M
3
Y
Alleghany Corp
Y
+$24.9M
4
CTXS
Citrix Systems Inc
CTXS
+$17M
5
ZEN
ZENDESK INC
ZEN
+$15.3M

Sector Composition

Rank Sector Weight
1 Financials 17.05%
2 Technology 12.34%
3 Consumer Discretionary 8.56%
4 Industrials 7.99%
5 Healthcare 7.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NBSE
1101
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$59.2K ﹤0.01%
15,550
– –
UIS icon
1102
Unisys
UIS
$208M
$59K ﹤0.01%
+11,544
New +$72.4K
EOSE icon
1103
Eos Energy Enterprises
EOSE
$1.51B
$58.6K ﹤0.01%
39,591
-1,647
-4% -$2.13K
OMIC
1104
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$55.7K ﹤0.01%
923
+93
+11% +$6.23K
HEPS
1105
D-Market Electronic Services & Trading
HEPS
$1.04B
$54.7K ﹤0.01%
82,886
+11,487
+16% +$8.46K
GNW icon
1106
Genworth Financial
GNW
$3.72B
$52.9K ﹤0.01%
10,000
– –
BIRD icon
1107
Smartbird Inc
BIRD
$22.7M
$52.7K ﹤0.01%
+1,090
New +$63.9K
TBLA icon
1108
Taboola.com
TBLA
$1.1B
$52.1K ﹤0.01%
16,900
-316,112
-95% -$671K
SYRS
1109
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$51.7K ﹤0.01%
+14,399
New +$62.5K
MJ icon
1110
Amplify Alternative Harvest ETF
MJ
$108M
$51.1K ﹤0.01%
1,000
– –
ZVIA icon
1111
Zevia
ZVIA
$108M
$51K ﹤0.01%
12,481
-300
-2% -$1.24K
ARQ icon
1112
Arq
ARQ
$99.6M
$50.3K ﹤0.01%
20,700
-100
-0.5% -$272
AIP icon
1113
Arteris
AIP
$1.36B
$49.9K ﹤0.01%
+11,600
New +$58.4K
OLMA icon
1114
Olema Pharmaceuticals
OLMA
$914M
$48.9K ﹤0.01%
19,951
+1,200
+6% +$3.5K
TYGOW
1115
DELISTED
Tigo Energy, Inc. Warrant
TYGOW
$48.3K ﹤0.01%
200,000
– –
MTTR
1116
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
$47.9K ﹤0.01%
+17,100
New +$54.7K
DAKT icon
1117
Daktronics
DAKT
$1.02B
$46.8K ﹤0.01%
16,600
-8,400
-34% -$25.8K
GRND icon
1118
Grindr
GRND
$2.85B
$46.5K ﹤0.01%
+10,000
New +$92.9K
AAC.WS
1119
DELISTED
Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
AAC.WS
$45.4K ﹤0.01%
97,405
-17,000
-15% -$3.33K
DNA icon
1120
CALL
Ginkgo Bioworks
DNA
$506M
$44.8K ﹤0.01%
663
-3,687
-85% -$339K
HLTH
1121
DELISTED
Cue Health Inc. Common Stock
HLTH
$44.3K ﹤0.01%
21,402
-3,900
-15% -$12.3K
ASRT
1122
DELISTED
Assertio
ASRT
$44.3K ﹤0.01%
687
– –
ROIVW
1123
DELISTED
Roivant Sciences Ltd. Warrant
ROIVW
$43.9K ﹤0.01%
22,606
– –
ORGO icon
1124
Organogenesis Holdings
ORGO
$235M
$43.1K ﹤0.01%
16,041
-1,983
-11% -$5.78K
RSI icon
1125
Rush Street Interactive
RSI
$2.91B
$42.9K ﹤0.01%
+11,962
New +$44.4K
43 44
45
46 47

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Prelude Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Prelude Capital Management held 1,961 positions worth $1.92B, down 31% from $2.79B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Prelude Capital Management withdrew a net $1.08B in Q4 2022, closing 669 positions and reducing 381 holdings. Its most notable exit was KKR Acquisition Holdings I Corp., an estimated $30.7M position sold in full.

By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 18% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Prelude Capital Management opened a new position in AVEO Pharmaceuticals, Inc. worth $7.55M.

  • Prelude Capital Management's largest Q4 2022 buy was AVEO Pharmaceuticals, Inc.: 504,972 shares worth $7.55M.
  • Prelude Capital Management added most to KE Holdings in Q4 2022, an estimated $13.6M increase.
  • Prelude Capital Management's biggest Q4 2022 reduction was Alphabet (Google) Class A, cutting an estimated $6.9M.
  • Prelude Capital Management fully exited KKR Acquisition Holdings I Corp. in Q4 2022, selling an estimated $30.7M.
  • Prelude Capital Management's ten largest holdings make up 25% of its $1.92B portfolio in Q4 2022.
  • Prelude Capital Management opened 419 new positions and closed 669 in Q4 2022.
  • Prelude Capital Management's portfolio value fell 31% quarter-over-quarter to $1.92B.

Based on Prelude Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.